# The Combination of High-dose Dexamethasone and Acetylcysteine as the Treatment of Newly-diagnosed ITP

> **NCT04368598** · PHASE2 · UNKNOWN · sponsor: **Peking University People's Hospital** · enrollment: 44 (estimated)

## Conditions studied

- Immune Thrombocytopenia

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** Acetylcysteine

## Key facts

- **NCT ID:** NCT04368598
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2020-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04368598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04368598, "The Combination of High-dose Dexamethasone and Acetylcysteine as the Treatment of Newly-diagnosed ITP". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04368598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*